Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
about
Exploiting Epigenetic Alterations in Prostate Cancer.Understanding nucleosome dynamics and their links to gene expression and DNA replication.The molecular underpinnings of prostate cancer: impacts on management and pathology practice.CHD1 regulates cell fate determination by activation of differentiation-induced genes.DNA repair goes hip-hop: SMARCA and CHD chromatin remodellers join the break dance.Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.Chromatin remodeler CHD1 promotes XPC-to-TFIIH handover of nucleosomal UV lesions in nucleotide excision repair.[Antihormonal therapy in prostate cancer : Side effects].CHD1 Controls Cell Lineage Specification Through Zygotic Genome Activation.Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.CHD1: a new treatment biomarker for recombination deficiency in castration resistant prostate cancer?Recent Advances in Prostate Cancer Treatment and Drug Discovery.Epigenetic Regulation in Prostate Cancer Progression.Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer.Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2.Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
P2860
Q33755160-06C8F414-4359-480A-B1F1-009CB2AEE046Q34557106-A3E2B335-1090-4270-9008-066C18FFC5EBQ38983790-E498390E-4A0D-42B4-B25B-0D93E72B4488Q41510943-DBB0F9B3-23E9-44F9-9B1D-E4CFE5FE550AQ41568111-D5B61DE6-C3B2-4187-B15F-FF94C40E0126Q42288449-572AF415-BF70-449B-B421-567EE93DE086Q46345647-70434C94-3451-4B19-9188-CA00FE834373Q47669368-F7C8E593-4A3D-4CE7-B754-9052E4FCDBDDQ48744603-491C9062-BB3A-43C2-BC91-52E7A6B51C8FQ49607461-64747F39-318F-4B85-8466-08AC3DDE0573Q49710396-3C2DD762-8F0F-4D45-AC3A-7FAFDB638E03Q51741278-06BFD9A9-CED4-46E0-90E2-FB20684A8FBCQ52566012-5195F14F-EA9B-4FAA-8325-F80C362364ACQ53743923-D2893A18-EB33-40C5-8881-C6450C5C2A1FQ54111821-F9811AC9-AC7F-42C2-954B-C75ACC3EF58DQ54974720-B1523797-CD29-4FCA-85DB-D7CCF49A3514Q55371418-E31615DA-63E7-4203-84E8-71430716E929Q55658855-CA22491D-92C7-444B-83F1-798832EC9671Q57108205-75D4C925-88CF-4A14-AEA1-52114CD9B2F7
P2860
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@en
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@nl
type
label
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@en
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@nl
prefLabel
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@en
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@nl
P2093
P2860
P50
P356
P1433
P1476
Loss of CHD1 causes DNA repair ...... er therapeutic responsiveness.
@en
P2093
Ekkehard Dikomey
Hüseyin Sirma
Marian Grade
Matthias Dobbelstein
Ronald Simon
Sanjay Kumar Raul
Simon J Baumgart
Vijayalakshmi Kari
P2860
P304
P356
10.15252/EMBR.201642352
P577
2016-09-05T00:00:00Z